2-tert-butyl-3-methylfuran | 98761-55-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: 2-tert-butyl-3-methylfuran
• 英文别名: 2-t-Butyl-3-methylfuran
• CAS: 98761-55-8
• 化学式: C₉H₁₄O
• 分子量: 138.21
• InChiKey: ZENIOKSZGZNGEE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  13.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-tert-butyl-3-methylfuran 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 作用下， 以 四氯化碳 、 苯 为溶剂， 反应 9.5h， 生成 2-tert-butyl-3-(diethoxyphosphorylmethyl)furan
  参考文献：
  名称：

  Synthesis and Phosphorylation of 2-, 3-, and 4-Halomethyl-5-tert-butylfurans

  摘要：

  Synthetic methods for preparing of 2-, 3-, and 4-halomethyl-5-tert-butylfurans are developed. It was established that the bromination of 3- and 4-methyl-2-tert-butylfurans with N-bromosuccinimide proceeds mainly at the free alpha-position of the furan ring, and not at the methyl group. Therefore, the target halomethylfurans were prepared through the corresponding 3- and 4-methoxymethyl derivatives. The obtained five products were phosphorylated with sodium diethyl phosphite under the conditions of the Michaelis-Becker reaction to give the corresponding phosphonates.

  DOI：

  10.1023/b:rugc.0000031868.97123.e1
• 作为产物：
  描述：

  (Z)-6,6-Diethoxy-2,2,4-trimethyl-hex-4-en-3-ol 在 草酸 、 silica gel 作用下， 以 二氯甲烷 为溶剂， 反应 0.25h， 生成 2-tert-butyl-3-methylfuran
  参考文献：
  名称：

  (E)-1-Bromo-3,3-diethoxy-1-propene (diethyl acetal of 3-bromoacrolein). A versatile synthon for the synthesis of furans, butenolides, and (Z)-allyl alcohols

  摘要：

  DOI：

  10.1021/jo00224a044

文献信息

• Hepatitis C Virus Inhibitors
  申请人：Bristol-Myers Squibb Company

  公开号：US20130183269A1

  公开（公告）日：2013-07-18

  The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

  本公开涉及抗病毒化合物，更具体地涉及能够抑制丙型肝炎病毒（HCV）编码的NS5A蛋白功能的化合物组合，包括这种组合的组成物，以及抑制NS5A蛋白功能的方法。
• PYRIDYL BENZOTHIOPHENES AS KINASE INHIBITORS
  申请人：Allergan, Inc.

  公开号：US20160102080A1

  公开（公告）日：2016-04-14

  This invention is directed to compounds, which are useful as protein kinase (PK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders, metabolic diseases inflammatory disorders and neurodegenerative disorders.

  这项发明涉及一种化合物，可用作蛋白激酶（PK）抑制剂，可用于治疗癌症、血管增生性疾病、纤维化疾病、系膜细胞增生性疾病、代谢性疾病、炎症性疾病和神经退行性疾病。
• PYRIDONE COMPOUNDS AND AGRICULTURAL AND HORTICULTURAL FUNGICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS
  申请人：MITSUI CHEMICALS AGRO, INC.

  公开号：US20200045968A1

  公开（公告）日：2020-02-13

  Pyridine compounds of Formula (1) are provided: wherein R1, R2, X, Y and Het are defined. The pyridine compounds can be used to treat or prevent plant diseases.

  提供了化合物的化学式（1）：其中R1、R2、X、Y和Het均已定义。这些吡啶化合物可用于治疗或预防植物疾病。
• ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
  申请人：Universal Display Corporation

  公开号：US20210002311A1

  公开（公告）日：2021-01-07

  Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

  提供了有机金属化合物。还提供了包含这些有机金属化合物的配方。进一步提供了利用这些有机金属化合物的OLED和相关消费品。
• Mitotic Kinesin Inhibitors and Methods of Use Thereof
  申请人：Hans Jeremy

  公开号：US20080182992A1

  公开（公告）日：2008-07-31

  This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.

  本发明涉及有丝分裂动力蛋白酶抑制剂，特别是KSP的抑制剂，以及制备这些抑制剂的方法。该发明还提供了包含该发明抑制剂的药物组合物，并且提供了利用该发明抑制剂和药物组合物在治疗和预防各种疾病中的方法。